KDA Group Inc. (TSXV:KDA)
Canada · Delayed Price · Currency is CAD 0.0950
-0.0050 (-5.00%)
At close: Aug 27, 2026
KDA Group Financials Overview
Financials in millions CAD. Fiscal year is August - July.
Millions CAD. Fiscal year is Aug - Jul.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Revenue Revenue Growth | 0.42 | 0.17 | 0.15 | 0.16 | 0.21 | 24.37 |
Revenue Growth | 99.32% | 12.20% | -8.51% | -22.20% | -99.15% | 6.45% |
Gross Profit Gross Profit Growth | -2.95 | -2.77 | -1.29 | 0.16 | 0.15 | 7.2 |
Operating Income Operating Income Growth | -6.66 | -8.83 | -4.77 | -3.31 | -4 | 1.43 |
Net Income Net Income Growth | -6.02 | -8.05 | -6.91 | 16.14 | -4.56 | 0.56 |
Earnings Per Share EPS Growth | -0.03 | -0.04 | -0.04 | 0.11 | -0.03 | 0.00 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Pharmaceutical Technology Pharmaceutical Technology Growth | 0.38 | 0.1 | 0.04 | 0.1 | 0.21 | - |
Corporate and Others Corporate and Others Growth | 0.04 | 0.07 | 0.11 | 0.07 | - | 0.07 |
Total Total Growth | 0.42 | 0.17 | 0.15 | 0.16 | 0.21 | 24.37 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Cash & Investments Cash & Investments Growth | 0.24 | 0.13 | 1.65 | 4.63 | 2.74 | 1.72 |
Total Debt Total Debt Growth | 0.73 | 0.87 | 0.94 | 3.26 | 22.67 | 13.57 |
Net Cash (Debt) Net Cash Growth | -0.49 | -0.74 | 0.7 | 1.37 | -19.93 | -11.85 |
Net Cash Growth | - | - | -48.64% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.00 | -0.00 | 0.00 | 0.01 | -0.13 | -0.09 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -0.97 | -2.36 | -1.89 | -0.84 | 1.28 | 2.94 |
Capital Expenditures CapEx Growth | -0.01 | -0 | -0.01 | -0 | -0.05 | -0.05 |
Free Cash Flow Free Cash Flow Growth | -0.99 | -2.37 | -1.9 | -0.85 | 1.24 | 2.9 |
Free Cash Flow Growth | - | - | - | - | -57.22% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Gross Margin | - | - | - | 100.00% | 73.29% | 29.55% |
Operating Margin | -1588.57% | -5336.13% | -3236.64% | -2053.85% | -1932.46% | 5.87% |
Pretax Margin | -1617.47% | -5392.96% | -5158.28% | 1534.75% | -4567.89% | 1.40% |
Profit Margin | -1437.21% | -4866.30% | -4686.11% | 10015.99% | -2203.03% | 2.30% |
FCF Margin | -235.11% | -1430.73% | -1291.25% | -526.74% | 598.08% | 11.88% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
PE Ratio | - | - | - | 0.84 | - | 34.16 |
P/FCF Ratio | - | - | - | - | 13.16 | 6.63 |
PS Ratio | 53.33 | 310.01 | 309.53 | 84.39 | 78.69 | 0.79 |